Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Briggs, R.
Right arrow Articles by Dessypris, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Briggs, R.
Right arrow Articles by Dessypris, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

The human myeloid cell nuclear differentiation antigen gene is one of at least two related interferon-inducible genes located on chromosome 1q that are expressed specifically in hematopoietic cells

RC Briggs, JA Briggs, J Ozer, L Sealy, LL Dworkin, SF Kingsmore, MF Seldin, GP Kaur, RS Athwal and EN Dessypris

Department of Pathology, Vanderbilt University, Nashville, TN 37232.

We have previously shown that the human myeloid cell nuclear differentiation antigen (MNDA) is expressed at both the antigen and mRNA levels specifically in human monocytes and granulocytes and earlier stage cells in the myeloid lineage. A 200 amino acid region of the MNDA is strikingly similar to a region in the proteins encoded by a family of interferon-inducible mouse genes, designated Ifi-201, Ifi- 202, Ifi-203, etc, that are not regulated in a cell- or tissue-specific fashion. However, a new member of the Ifi-200 gene family, D3, is induced in mouse mononuclear phagocytes but not in fibroblasts by interferon. The same 200 amino acid region, duplicated in the mouse Ifi- 200 gene family, is also repeated in the recently characterized human IFI 16 gene that is constitutively expressed specifically in lymphoid cells and is induced in myeloid cells by interferon gamma. The 1.8-kb MNDA mRNA, which contains an interferon-stimulated response element in the 5' untranslated region, was significantly upregulated in human monocytes exposed to interferon alpha. Characterization of the MNDA gene showed that it is a single-copy gene and localized to human chromosome 1q 21-22 within the large linkage group conserved between mouse and human that contains the Ifi-200 gene family. The IFI 16 gene is also located on human chromosome 1q. Our observations are consistent with the proposal that the MNDA is a member of a cluster of related human interferon-regulated genes, similar to the mouse Ifi-200 gene family. In addition, one mouse gene in the Ifi-200 gene family and the human MNDA and IFI 16 genes show expression and/or regulation restricted to cells of the hematopoietic system, suggesting that these genes participate in blood cell-specific responses to interferons.

Volume 83, Issue 8, pp. 2153-2162, 04/15/1994
Copyright © 1994 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
R. C. Briggs, K. E. Shults, L. A. Flye, S. A. McClintock-Treep, M. H. Jagasia, S. A. Goodman, F. I. Boulos, J. W. Jacobberger, G. T. Stelzer, and D. R. Head
Dysregulated Human Myeloid Nuclear Differentiation Antigen Expression in Myelodysplastic Syndromes: Evidence for a Role in Apoptosis.
Cancer Res., May 1, 2006; 66(9): 4645 - 4651.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. M. Dermott, J. M. Gooya, B. Asefa, S. R. Weiler, M. Smith, and J. R. Keller
Inhibition of Growth by p205: A Nuclear Protein and Putative Tumor Suppressor Expressed during Myeloid Cell Differentiation
Stem Cells, September 1, 2004; 22(5): 832 - 848.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Wagner, A. Ansorge, U. Wirkner, V. Eckstein, C. Schwager, J. Blake, K. Miesala, J. Selig, R. Saffrich, W. Ansorge, et al.
Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis
Blood, August 1, 2004; 104(3): 675 - 686.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
T. Shiina, A. Ando, Y. Suto, F. Kasai, A. Shigenari, N. Takishima, E. Kikkawa, K. Iwata, Y. Kuwano, Y. Kitamura, et al.
Genomic Anatomy of a Premier Major Histocompatibility Complex Paralogous Region on Chromosome 1q21-q22
Genome Res., May 1, 2001; 11(5): 789 - 802.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. K. Roy, S. J. Wachira, X. Weihua, J. Hu, and D. V. Kalvakolanu
CCAAT/Enhancer-binding Protein-beta Regulates Interferon-induced Transcription through a Novel Element
J. Biol. Chem., April 21, 2000; 275(17): 12626 - 12632.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. R. Weiler, J. M. Gooya, M. Ortiz, S. Tsai, S. J. Collins, and J. R. Keller
D3: A Gene Induced During Myeloid Cell Differentiation of Linlo c-Kit+ Sca-1+ Progenitor Cells
Blood, January 15, 1999; 93(2): 527 - 536.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Itoh, K. Okubo, H. Utiyama, T. Hirano, J. Yoshii, and K. Matsubara
Expression Profile of Active Genes in Granulocytes
Blood, August 15, 1998; 92(4): 1432 - 1441.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Datta, B. Li, D. Choubey, G. Nallur, and P. Lengyel
p202, an Interferon-inducible Modulator of Transcription, Inhibits Transcriptional Activation by the p53 Tumor Suppressor Protein, and a Segment from the p53-binding Protein 1That Binds to p202 Overcomes This Inhibition
J. Biol. Chem., November 1, 1996; 271(44): 27544 - 27555.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1994 by American Society of Hematology         Online ISSN: 1528-0020